National Research/$NRC
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About National Research
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
Ticker
$NRC
Sector
Primary listing
Employees
357
Headquarters
Website
NRC Metrics
BasicAdvanced
$411m
47.31
$0.39
0.41
$0.56
3.51%
Price and volume
Market cap
$411m
Beta
0.41
52-week high
$22.79
52-week low
$11.01
Average daily volume
80k
Dividend rate
$0.56
Financial strength
Current ratio
0.519
Quick ratio
0.348
Long term debt to equity
548.477
Total debt to equity
578.229
Dividend payout ratio (TTM)
130.97%
Interest coverage (TTM)
5.15%
Profitability
EBITDA (TTM)
34.602
Gross margin (TTM)
61.80%
Net profit margin (TTM)
6.52%
Operating margin (TTM)
19.01%
Effective tax rate (TTM)
37.69%
Revenue per employee (TTM)
$390,000
Management effectiveness
Return on assets (TTM)
12.21%
Return on equity (TTM)
41.86%
Valuation
Price to earnings (TTM)
47.314
Price to revenue (TTM)
2.903
Price to book
30.43
Price to tangible book (TTM)
-7.8
Price to free cash flow (TTM)
23.091
Free cash flow yield (TTM)
4.33%
Free cash flow per share (TTM)
0.789
Dividend yield (TTM)
3.07%
Forward dividend yield
3.51%
Growth
Revenue change (TTM)
-1.88%
Earnings per share change (TTM)
-62.25%
3-year revenue growth (CAGR)
-2.50%
10-year revenue growth (CAGR)
2.92%
3-year earnings per share growth (CAGR)
-31.72%
10-year earnings per share growth (CAGR)
-6.98%
3-year dividend per share growth (CAGR)
-8.04%
10-year dividend per share growth (CAGR)
7.18%
NRC Financial Performance
Revenues and expenses
NRC News
AllArticlesVideos
The Governance Institute Releases Falling Behind Report, Warning Health System Operations Are Advancing Faster than Governance
Business Wire·1 week ago
Piedmont Names NRC Health as a Strategic Experience Partner to Support Mission-Driven Growth
Business Wire·2 months ago
NRC Health Announces Board Authorization of $60 Million Share Repurchase Program
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for National Research stock?
National Research (NRC) has a market cap of $411M as of May 05, 2026.
What is the P/E ratio for National Research stock?
The price to earnings (P/E) ratio for National Research (NRC) stock is 47.31 as of May 05, 2026.
Does National Research stock pay dividends?
Yes, the National Research (NRC) stock pays dividends to shareholders. As of May 05, 2026, the dividend rate is $0.56 and the yield is 3.51%. National Research has a payout ratio of 130.97% on a trailing twelve-month basis.
When is the next National Research dividend payment date?
The next National Research (NRC) dividend payment is scheduled for July 10, 2026.
What is the beta indicator for National Research?
National Research (NRC) has a beta rating of 0.41. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.